Author

Z. Hunter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Mackay-Sim· 1 shared A. Taherian Fard· 1 shared C. Buske· 1 shared C. Gomez-Inclan· 1 shared D. Sauter· 1 shared D. Tews· 1 shared E. Hildt· 1 shared E. J. Wolvetang· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Mackay-Sim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ataxia Telangiectasia patient-derived neuronal and brain organoid models reveal mitochondrial dysfunction and oxidative stress

H. C. Leeson, J. Aguado, C. Gomez-Inclan, H. K. Chaggar, A. Taherian Fard, Z. Hunter, M. F. Lavin, A. Mackay-Sim, E. J. Wolvetang

This study uses patient-derived iPSCs and organoids to show mitochondrial dysfunction and oxidative stress in AT, which can be mitigated by ATM correction or antioxidants.

bioRxiv · Jan 29, 2024Cell Biology

CXCR4 signaling is counteracted by the naturally occurring CXCR4 antagonist EPI-X 4 in Waldenstrom Macroglobulinemia

L. M. Kaiser, M. Harms, D. Sauter, V. P. Rawat, M. Glitscher, E. Hildt, D. Tews, Z. Hunter, J. Muench, C. Buske

This study shows that the natural CXCR4 antagonist EPI-X4 inhibits Waldenstrom Macroglobulinemia cell growth and migration, with optimized derivatives showing enhanced efficacy.

bioRxiv · Oct 19, 2020 · PreprintCancer Biology